Marc Hickel thought his battle with prostate cancer was over after surgery and radiation treatment. But five years later, ...

Enfortumab vedotin plus pembrolizumab improved EFS, OS, and pCR rates in MIBC patients ineligible for cisplatin-based chemotherapy. The combination therapy showed a median EFS and OS that were not ...

Patients with muscle-invasive bladder cancer who test positive for circulating tumor (ct)DNA after surgery to remove the ...

TWELVE members of the East Cornwall Harriers are preparing to take on the challenging Cornish Marathon on November 2, running in support of fellow club member Craig Vaughnley, who is currently ...

A 31-year-old woman’s mild urinary infection escalated into kidney stones and septic shock. Know the warning signs you should ...

Tecentriq reduced the risk of death by 41% and the risk of disease recurrence or death by 36% compared with placebo –– ...

IT’S been 18 months since Evan Francis last peed naturally, and shockingly she never will again. Her ordeal started with an ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. today announced positive results from the pivotal Phase 3 EV-303 clinical trial (also known as ...

It's easy to overlook the bladder - until it starts causing problems. However, just like the heart or lungs, this vital organ ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced landmark results demonstrating ...

Rams have an unusual travel plan for London game that no NFL team has ever attempted California labor leader charged over ...

Durvalumab addition to BCG therapy significantly improved DFS in BCG-naive, high-risk NMIBC patients, achieving a 32% reduction in DFS event risk. The combination therapy was well-tolerated, with ...